The FDA-cleared Res-Q technology is a point-of-care platform designed to prepare cell concentrates. Once prepared, the PRP is mixed with autograft or allograft bone prior to application.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
Arthrex Partners With ThermoGenesis for PRP System Distribution
ThermoGenesis, a Rancho Cordova, Calif.-based medical device company, recently partnered with Arthrex to market the ThermoGenesis Res-Q 60 System for preparing autologous platelet-rich plasma and bone marrow concentrate, according to a company news release.
POCUS without chaos: How health systems build workflows that actually work
Recommended Live Webinar on Jan 27, 2026 3:00 PM - 4:00 PM CST